Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL
Crossref DOI link: https://doi.org/10.1007/s00262-021-03040-0
Published Online: 2021-09-07
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reusing, Sarah B.
Vallera, Dan A.
Manser, Angela R.
Watrin, Titus
Bhatia, Sanil
Felices, Martin
Miller, Jeffrey S.
Uhrberg, Markus
Babor, Florian http://orcid.org/0000-0002-6078-9993
Text and Data Mining valid from 2021-09-07
Version of Record valid from 2021-09-07
Article History
First Online: 7 September 2021